The post Another Cross-Chain Protocol Falls Victim to Bridge Exploit appeared on BitcoinEthereumNews.com. Crime Cross-chain protocol CrossCurve has confirmed anThe post Another Cross-Chain Protocol Falls Victim to Bridge Exploit appeared on BitcoinEthereumNews.com. Crime Cross-chain protocol CrossCurve has confirmed an

Another Cross-Chain Protocol Falls Victim to Bridge Exploit

Crime

Cross-chain protocol CrossCurve has confirmed an active security incident after attackers exploited a flaw in one of its bridge-related smart contracts, draining roughly $3 million in assets across multiple blockchain networks.

Key Takeaways
  • CrossCurve suffered an estimated $3 million loss after a flaw allowed spoofed cross-chain messages to bypass validation.
  • The exploit targeted bridge-related smart contracts and affected multiple networks.
  • Partners and users are being urged to reassess exposure as investigations remain ongoing.

The team acknowledged the breach in a public statement, warning users to immediately halt all interactions with CrossCurve while an internal investigation is underway. According to the protocol, the attack stems from a vulnerability tied to its cross-chain infrastructure rather than user-facing applications.

How the exploit unfolded

Blockchain security monitor Defimon Alerts traced the incident to a weakness in a contract linked to CrossCurve’s Axelar-based message handling. The flaw allowed malicious actors to forge cross-chain messages and bypass standard validation checks, ultimately triggering unauthorized token unlocks on the PortalV2 contract.

In practical terms, attackers were able to call a privileged execution function using spoofed data, giving them access to funds that should have remained locked. On-chain data indicates the exploit was carried out on several networks, suggesting a coordinated and automated attack rather than a single isolated transaction.

Multiple attacker addresses have already been identified, and fund movements show a rapid outflow shortly after the exploit was initiated.

Protocol response and ecosystem impact

CrossCurve stated that it is actively working with security partners to assess the full scope of the damage and determine whether additional contracts may be affected. No timeline has been given yet for a potential fix or the resumption of normal operations.

The incident has also prompted caution from partners in the broader DeFi ecosystem. Curve Finance, which has existing integrations with CrossCurve, advised users exposed to CrossCurve-linked pools to reassess their positions and consider withdrawing governance support tied to those allocations.

While Curve emphasized that its own core contracts remain unaffected, the message underscored growing concerns around third-party risk, particularly in cross-chain systems where complexity can amplify the impact of a single vulnerability.

Cross-chain security under renewed scrutiny

This latest exploit adds to a growing list of bridge-related incidents, reinforcing long-standing warnings from security researchers about the risks of cross-chain message verification. Even protocols with strong liquidity and reputable partners remain vulnerable if validation layers can be circumvented.

As investigations continue, users are being urged to monitor official updates closely and avoid interacting with CrossCurve contracts until a full post-mortem and remediation plan are released.


The information provided in this article is for educational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Author

Alexander Zdravkov is a person who always looks for the logic behind things. He has more than 3 years of experience in the crypto space, where he skillfully identifies new trends in the world of digital currencies. Whether providing in-depth analysis or daily reports on all topics, his deep understanding and enthusiasm for what he does make him a valuable member of the team.

Next article

Source: https://coindoo.com/another-cross-chain-protocol-falls-victim-to-bridge-exploit/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26